Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stiefel Labs Adds Connetics’ Topical Delivery Technology With Acquisition Of Dermatology Firm

This article was originally published in The Pink Sheet Daily

Executive Summary

Completion of the $640 million acquisition combines Stiefel’s dermatology portfolio with Connectics’ patented drug delivery technology.
Advertisement

Related Content

GSK’s Stiefel Adds Psoriasis/Atopical Dermatitis Candidate In Licensing Deal
Dermatology Space Waits For Skinny On Stiefel Buyout
Dermatology Space Waits For Skinny On Stiefel Buyout
Connetics’ Velac Is “Not Approvable” For Acne
Connetics’ Velac Is “Not Approvable” For Acne

Topics

Advertisement
UsernamePublicRestriction

Register

PS063618

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel